Full name
ARTFARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
52.10.B - Warehousing and storage of other goods
68.10.Z - Real estate activities on own account and development of building projects
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | -0,1 | -0,1 | -53,8 |
Gross profit (loss) | -0,2 | -0,8 | -0,4 | 47,6 |
EBITDA | -0,2 | -0,1 | -0,1 | -24,1 |
Short time liabilities | 18,7 | 19,8 | 33,1 | 67,4 |
Other operating costs | 0,1 | 0,1 | 0,1 | 15,5 |
Equity capital | -3,1 | -3,9 | -4,3 | -10,7 |
Operating profit (EBIT) | -0,2 | -0,1 | -0,2 | -10,9 |
Assets | 15,7 | 16 | 28,9 | 80,9 |
Net profit (loss) | -0,2 | -0,8 | -0,4 | 47,2 |
Cash | 0 | 0 | 0 | -7,8 |
Net income from sale | 6,9 | 7,8 | 8,8 | 12,3 |
Liabilities and provisions for liabilities | 18,8 | 19,9 | 33,2 | 67,2 |
Working assets | 1,2 | 1,6 | 1,8 | 12,5 |
Other income costs | 0 | 0 | 0,1 | 174,6 |
Depreciation | 0 | 0 | 0 | -24,3 |
% | % | % | p.p. | |
Profitability of capital | 8 | 20,2 | 9,6 | -10,6 |
Equity capital to total assets | -19,7 | -24,2 | -14,8 | 9,4 |
Gross profit margin | -3,6 | -10 | -4,7 | 5,3 |
EBITDA Margin | -2,5 | -1,4 | -1,5 | -0,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 991 | 922 | 1376 | 454 |
Current financial liquidity indicator | 0.06455300003290176 | 0.08123128116130829 | 0.05456811934709549 | 0 |
Net dept to EBITDA | 0.07998793572187424 | 0.256879985332489 | 0.19088006019592285 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane